Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 07/31/12
Due: 07/31/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00726986 | Afshin Dowlati, MD | user2@example.com | None | 2008-07-31 | 2012-07-31 | 2013-07-31 | - | - | 2025-07-14 |